119 related articles for article (PubMed ID: 10971598)
1. Interictal hippocampal benzodiazepine receptors in temporal lobe epilepsy: comparison with coregistered hippocampal metabolism and volumetry.
Szelies B; Weber-Luxenburger G; Mielke R; Pawlik G; Kessler J; Pietrzyk U; Bauer B; Heiss WD
Eur J Neurol; 2000 Jul; 7(4):393-400. PubMed ID: 10971598
[TBL] [Abstract][Full Text] [Related]
2. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy.
Szelies B; Weber-Luxenburger G; Pawlik G; Kessler J; Holthoff V; Mielke R; Herholz K; Bauer B; Wienhard K; Heiss WD
Neuroimage; 1996 Apr; 3(2):109-18. PubMed ID: 9345482
[TBL] [Abstract][Full Text] [Related]
3. Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis.
Koepp MJ; Labbé C; Richardson MP; Brooks DJ; Van Paesschen W; Cunningham VJ; Duncan JS
Brain; 1997 Oct; 120 ( Pt 10)():1865-76. PubMed ID: 9365376
[TBL] [Abstract][Full Text] [Related]
4. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy.
Juhász C; Nagy F; Watson C; da Silva EA; Muzik O; Chugani DC; Shah J; Chugani HT
Neurology; 1999 Dec; 53(9):2037-45. PubMed ID: 10599778
[TBL] [Abstract][Full Text] [Related]
5. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI.
Koepp MJ; Hammers A; Labbé C; Woermann FG; Brooks DJ; Duncan JS
Neurology; 2000 Jan; 54(2):332-9. PubMed ID: 10668692
[TBL] [Abstract][Full Text] [Related]
6. 11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy.
Koepp MJ; Richardson MP; Labbé C; Brooks DJ; Cunningham VJ; Ashburner J; Van Paesschen W; Revesz T; Duncan JS
Neurology; 1997 Sep; 49(3):764-73. PubMed ID: 9305338
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI.
Hammers A; Koepp MJ; Hurlemann R; Thom M; Richardson MP; Brooks DJ; Duncan JS
Brain; 2002 Oct; 125(Pt 10):2257-71. PubMed ID: 12244083
[TBL] [Abstract][Full Text] [Related]
8. In vivo measurement of hippocampal GABAA/cBZR density with [18F]-flumazenil PET for the study of disease progression in an animal model of temporal lobe epilepsy.
Vivash L; Gregoire MC; Bouilleret V; Berard A; Wimberley C; Binns D; Roselt P; Katsifis A; Myers DE; Hicks RJ; O'Brien TJ; Dedeurwaerdere S
PLoS One; 2014; 9(1):e86722. PubMed ID: 24466212
[TBL] [Abstract][Full Text] [Related]
9. 18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy.
Vivash L; Gregoire MC; Lau EW; Ware RE; Binns D; Roselt P; Bouilleret V; Myers DE; Cook MJ; Hicks RJ; O'Brien TJ
J Nucl Med; 2013 Aug; 54(8):1270-7. PubMed ID: 23857513
[TBL] [Abstract][Full Text] [Related]
10. In vivo hippocampal glucose metabolism in mesial temporal lobe epilepsy.
Knowlton RC; Laxer KD; Klein G; Sawrie S; Ende G; Hawkins RA; Aassar OS; Soohoo K; Wong S; Barbaro N
Neurology; 2001 Oct; 57(7):1184-90. PubMed ID: 11591833
[TBL] [Abstract][Full Text] [Related]
11. In vivo [11C]flumazenil-PET correlates with ex vivo [3H]flumazenil autoradiography in hippocampal sclerosis.
Koepp MJ; Hand KS; Labbé C; Richardson MP; Van Paesschen W; Baird VH; Cunningham VJ; Bowery NG; Brooks DJ; Duncan JS
Ann Neurol; 1998 May; 43(5):618-26. PubMed ID: 9585356
[TBL] [Abstract][Full Text] [Related]
12. [11C]Flumazenil PET in patients with epilepsy with dual pathology.
Juhász C; Nagy F; Muzik O; Watson C; Shah J; Chugani HT
Epilepsia; 1999 May; 40(5):566-74. PubMed ID: 10386525
[TBL] [Abstract][Full Text] [Related]
13. [11 C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology.
Lamusuo S; Pitkänen A; Jutila L; Ylinen A; Partanen K; Kälviäinen R; Ruottinen HM; Oikonen V; Någren K; Lehikoinen P; Vapalahti M; Vainio P; Rinne JO
Neurology; 2000 Jun; 54(12):2252-60. PubMed ID: 10881249
[TBL] [Abstract][Full Text] [Related]
14. Bilateral reductions of hippocampal volume, glucose metabolism, and wada hemispheric memory performance are related to the duration of mesial temporal lobe epilepsy.
Jokeit H; Ebner A; Arnold S; Schüller M; Antke C; Huang Y; Steinmetz H; Seitz RJ; Witte OW
J Neurol; 1999 Oct; 246(10):926-33. PubMed ID: 10552240
[TBL] [Abstract][Full Text] [Related]
15. Impaired benzodiazepine receptor binding in peri-lesional cortex of patients with symptomatic epilepsies studied by [(11)C]-flumazenil PET.
Szelies B; Sobesky J; Pawlik G; Mielke R; Bauer B; Herholz K; Heiss WD
Eur J Neurol; 2002 Mar; 9(2):137-42. PubMed ID: 11882054
[TBL] [Abstract][Full Text] [Related]
16. Is interictal temporal hypometabolism related to mesial temporal sclerosis? A positron emission tomography/magnetic resonance imaging confrontation.
Semah F; Baulac M; Hasboun D; Frouin V; Mangin JF; Papageorgiou S; Leroy-Willig A; Philippon J; Laplane D; Samson Y
Epilepsia; 1995 May; 36(5):447-56. PubMed ID: 7614921
[TBL] [Abstract][Full Text] [Related]
17. Neocortical temporal FDG-PET hypometabolism correlates with temporal lobe atrophy in hippocampal sclerosis associated with microscopic cortical dysplasia.
Diehl B; LaPresto E; Najm I; Raja S; Rona S; Babb T; Ying Z; Bingaman W; Lüders HO; Ruggieri P
Epilepsia; 2003 Apr; 44(4):559-64. PubMed ID: 12681005
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy.
Padma MV; Simkins R; White P; Satter M; Christian BT; Dunigan K; Lee C; Jacobs M; Mukherjee J; Mantil JC
Neurol India; 2004 Dec; 52(4):457-62. PubMed ID: 15626833
[TBL] [Abstract][Full Text] [Related]
19. Temporal lobe epilepsy with sensory aura: interictal glucose hypometabolism.
Wunderlich G; Schüller MF; Ebner A; Holthausen H; Tuxhorn I; Witte OW; Seitz RJ
Epilepsy Res; 2000 Feb; 38(2-3):139-49. PubMed ID: 10642042
[TBL] [Abstract][Full Text] [Related]
20. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy.
Henry TR; Frey KA; Sackellares JC; Gilman S; Koeppe RA; Brunberg JA; Ross DA; Berent S; Young AB; Kuhl DE
Neurology; 1993 Oct; 43(10):1998-2006. PubMed ID: 8413957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
